Qinghua Dong

1.4k citations
34 papers · 1.1k indexed · h-index 18
Topics
MicroRNA in disease regulation (5 papers)Epigenetics and DNA Methylation (4 papers)RNA modifications and cancer (4 papers)

In The Last Decade

Qinghua Dong

33 papers receiving 1.1k citations

Peers

Qinghua Dong
Comparison fields: 5 of 112
  • Molecular Biology 635
  • Oncology 291
  • Cancer Research 266
  • Immunology 123
  • Pulmonary and Respiratory Medicine 85
Replace Luigi Mele with:
Luigi Mele Italy
Xi Yu China
Agnes Gardner United States
Hengyuan Li China
Anna Pryczynicz Poland
Kangkai Wang China
Ming Tat Ling Hong Kong
Yu‐Tang Chin Taiwan
Qinghua Dong relative to Luigi Mele Italy Luigi Mele's profile →
Citations per field
00.5×1.6×
Luigi Mele · 1×
Citations per year

Countries citing papers authored by Qinghua Dong

Since Specialization
Citations

This map shows the geographic impact of Qinghua Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinghua Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinghua Dong more than expected).

Fields of papers citing papers by Qinghua Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qinghua Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinghua Dong. The network helps show where Qinghua Dong may publish in the future.

Co-authorship network of co-authors of Qinghua Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Qinghua Dong. A scholar is included among the top collaborators of Qinghua Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qinghua Dong. Qinghua Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 5
4 28
5 22
6 93
7 73
8 16
9 117
10 54
11 22
12 30
13 37
14 46
15
Abstract #5604: Bmi-1 protects human oral epithelial cells from ionizing radiation
1
16 100
17 37
18
[Knockdown of PLK1 mRNA by special siRNA].
3
19 61
20 5

About Qinghua Dong

Qinghua Dong is a scholar working on Developmental Neuroscience, Cancer Research and Biotechnology, having authored 34 papers that have together received 1.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (5 papers), Epigenetics and DNA Methylation (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (266 citations), Oncology (291 citations) and Molecular Biology (635 citations). Qinghua Dong has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Guanyu Wang, Sherven Sharma, Long Chen, Rongzhen Xu, Mo Kang, Ju-Eun Oh, Qinghua Lu, Jun Zheng, Q.M. Li and Kihyuk Shin. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026